Leerink Partners reiterated an Outperform rating and $26.00 price target on Aquinox Pharmaceutical (NASDAQ: AQXP) after attending an investor day ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Cowen Raises Price Target on Aquinox Pharma (AQXP) Following R&D Day October 12, 2015 7:56 AM Aquinox Pharma (AQXP) Will Review Full LEADERSHIP Trial Data at R&D DayOctober 7, 2015 9:20 AM Notable Analyst Rating Changes 10/6: (CSAL) (FDX) (NUVA) Upgraded; (HPY) (CMA) (TDY) DowngradedOctober 6, 2015 10:30 AM Pre-Open Stock Movers 10/06: (PMCS) (STRZA) (DD) Higher; (EXAS) (ILMN) (TCS) Lower (more...)October 6, 2015 9:23 AM Guggenheim Starts Aquinox Pharmaceutical (AQXP) at BuyOctober 6, 2015 7:33 AM